Area of research
Neurology · Cancer Research
Research interest
Research interests include Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Renal and related cancers, and Glioma Diagnosis and Treatment.
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes
Targeted therapies in children with renal cell carcinoma (<scp>RCC</scp>): An International Society of Pediatric Oncology—Renal Tumor Study Group (<scp>SIOP‐RTSG</scp>)‐related retrospective descriptive study
Mutational spectrum of <i>ATRX</i> aberrations in neuroblastoma and associated patient and tumor characteristics
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (<scp>SIOP</scp>) 93‐01, 2001 and <scp>UK‐IMPORT</scp> database: A report of the <scp>SIOP‐Renal</scp> Tumor Study Group
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review
Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma